Literature DB >> 11514571

Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells.

E Zhukova1, J Sinnett-Smith, E Rozengurt.   

Abstract

We examined whether protein kinase D (PKD) overexpression in Swiss 3T3 cells potentiates the proliferative response to either the G protein-coupled receptor agonists bombesin and vasopressin or the biologically active phorbol ester phorbol 12,13-dibutyrate (PDBu). In order to generate Swiss 3T3 cells stably overexpressing PKD, cultures of these cells were infected with retrovirus encoding murine PKD and green fluorescent protein (GFP) expressed as two separate proteins translated from the same mRNA. GFP was used as a marker for selection of PKD-positive cells. PKD overexpressed in Swiss 3T3 cells was dramatically activated by cell treatment with bombesin or PDBu as judged by in vitro kinase autophosphorylation assays and exogenous substrate phosphorylation. Concomitantly, these stimuli induced PKD phosphorylation at Ser(744), Ser(748), and Ser(916). PKD activation and phosphorylation were prevented by exposure of the cells to protein kinase C-specific inhibitors. Addition of bombesin, vasopressin, or PDBu to cultures of Swiss 3T3 cells overexpressing PKD induced a striking increase in DNA synthesis and cell number compared with cultures of Swiss 3T3-GFP cells. In contrast, stimulation of DNA synthesis in response to epidermal growth factor, which acts via protein kinase C/PKD-independent pathways, was not enhanced. Our results demonstrate that overexpression of PKD selectively potentiates mitogenesis induced by bombesin, vasopressin, or PDBu in Swiss 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514571     DOI: 10.1074/jbc.M106512200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

2.  Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization.

Authors:  Jen-Kuan Chang; Yang Ni; Liang Han; James Sinnett-Smith; Rodrigo Jacamo; Osvaldo Rey; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

Review 3.  Role of protein kinase D signaling in pancreatic cancer.

Authors:  Sushovan Guha; Suebpong Tanasanvimon; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Pharmacol       Date:  2010-07-16       Impact factor: 5.858

4.  PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle.

Authors:  Tianzhou Zhang; Ursula Braun; Michael Leitges
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

5.  Protein kinase D1 mediates stimulation of DNA synthesis and proliferation in intestinal epithelial IEC-18 cells and in mouse intestinal crypts.

Authors:  James Sinnett-Smith; Nora Rozengurt; Robert Kui; Carlos Huang; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

6.  Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells.

Authors:  Krisztina Kisfalvi; Cliff Hurd; Sushovan Guha; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

7.  Protein kinase D mediates mitogenic signaling by Gq-coupled receptors through protein kinase C-independent regulation of activation loop Ser744 and Ser748 phosphorylation.

Authors:  James Sinnett-Smith; Rodrigo Jacamo; Robert Kui; Yunzu M Wang; Steven H Young; Osvaldo Rey; Richard T Waldron; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 8.  Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.

Authors:  Nisha Durand; Sahra Borges; Peter Storz
Journal:  Cell Mol Life Sci       Date:  2015-08-08       Impact factor: 9.261

Review 9.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

10.  Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells.

Authors:  J-I Ukegawa; Y Takeuchi; S Kusayanagi; K Mitamura
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-14       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.